The 2024 WTA Tour season has come to an end and there is a new name at the top of the WTA Rankings with Aryna Sabalenka claiming the year-end No 1 ranking for the first time.

Dr. Raad Haddad, MD works in Philadelphia, PA as a Diabetes & Metabolism Endocrinologist and has 13 years experience. Dr. Haddad is board certified in Diabetes, Metabolism & Endocrinology and ...

Canada has the task of defending their Billie Jean King Cup Finals title which saw Leylah Fernandez anchor their efforts in 2023. But they won't be backed up by Bianca Andreescu who has withdrawn ...

Former world number one Caroline Wozniacki has shared an interesting video about being hit by her daughter with full force while playing an indoor game. The 34-year-old was once regarded as one of ...

No. 1 seed Diana Shnaider outlasted Suzan Lamens 6-0, 6-7 (4), 6-2 on Friday to advance to the semifinals of the Hong Kong Tennis Open. Read more at straitstimes.com.

In the Round of 16 at the Jiangxi Open on Wednesday, Sijia Wei (ranked No. 132) faces Rebecca Sramkova (No. 53).Wei’s last ...

CHICAGO, October 28, 2024--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company ...

The Executive Council of Australian Jewry announced the action against Wissam Haddad – also known as Abu Ousayd – and the religious centre Al Madina Dawah Centre Incorporated that hosts the ...

On Friday, the Executive Council of Australian Jewry instigated proceedings in the Federal Court against extremist preacher Wissam Haddad, also known as Abu Ousayd, and his Bankstown-based Al ...

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing ...

The Executive Council of Australian Jewry announced on Monday it had started the Federal Court proceedings against Wissam Haddad and his Bankstown religious centre Al Madina Dawah Centre.

MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it ...